Clinical trial Recruiting at 1 site Observational Ages 18 and up

Five Digits Test: a quick inhibition test for adults with ADHD or autism

Official title: Five Digits Test - Validation of a Neuropsychological Test of Inhibition for Patients With Neuropsychiatric Conditions

Run by Umeå University · NCT07531914 · Data updated 2026-11-12

This project will test whether the Five Digits Test is a quick, language-light way to measure inhibition in adults with ADHD or autism.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment150 (estimated)
SponsorUmeå University
Academic / other
Locations1 site (Umeå)
StatusRecruiting
StartedJanuary 21, 2026
Main results expectedDecember 2027
Study endsDecember 2027
Registry record updatedApril 15, 2026
Trial IDNCT07531914 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) diagnosed with or under evaluation for ADHD or autism who can read Swedish well enough to consent and complete testing and are able to undergo neuropsychological assessment are ideal candidates.

Probably not a fit

People with active alcohol or drug addiction, those taking sedatives that affect testing, non-Swedish speakers who cannot consent, or individuals unable to complete neuropsychological testing are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a cross-sectional validation comparing the Five Digits Test (FDT) to the standard Color-Word Interference Test (CWIT) and the BRIEF-A questionnaire in adults with diagnosed or suspected ADHD or autism and healthy controls. Participants complete demographic and health questions, then are randomly assigned to take the FDT or CWIT first to control for order and learning effects. Researchers will use correlation coefficients to examine convergent validity and perform regressions and group comparisons (t-tests/ANCOVAs) to adjust for background variables and test differences. The protocol excludes people with active substance addiction, insufficient Swedish language to consent, current sedative use, or inability to complete neuropsychological testing.

Why it matters

Potential benefit: If successful, the FDT could give clinicians a simpler, lower-language-demand tool to measure inhibition, helpful for patients with limited reading or language skills.

How similar studies have gone: The CWIT and BRIEF-A are well-established measures of inhibition and executive function, while the FDT is a newer, less-tested tool with limited prior validation data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* age 18 and above
* Diagnosed with a ADHD or Autism, alternatively under examination these diagnoses

Exclusion Criteria:

* Addiction of alcohol or other substances
* Not speaker of Swedish to such extent that cannot read or comprehend the informed consent forms
* On sedatives, such as sleep or pain medication
* Not being able to participate in a neuropsychological examination, or to give informed consent

Where it's running

  • Umeå University, Umeå University Hospital
    Umeå, Sweden
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.